PHIO

Phio Pharmaceuticals
$1.05
+$0.01 (+0.96%)Jul 27, 2026
0.6PoorMoatMint rating

MoatMint rates Phio Pharmaceuticals (PHIO) 0.6 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 0.3 out of 10.

Key metrics

The numbers that frame PHIO today
Market cap
$12.20M
P/E (TTM)
-1.1
EV / FCF
0.4
ROIC
1,458.1%
Div yield
0%
Debt / equity
0.0
52wk Low
$0.81
52wk High
$4.19

PHIO stock rating

How PHIO scores on quality, value, growth, momentum and financial health
0.6out of 10
Low overallNeutral business, valuation unclearTop 94% of ~5,000 US stocks
QualityPoor0.3/10
GrowthFair3.5/10
MomentumPoor1.5/10
ValueNo scoren/a/10
Financial HealthPoor1.5/10

Growth

Revenue and earnings trend for PHIO
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about PHIO
Is Phio Pharmaceuticals a good buy?
No. Phio Pharmaceuticals has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks weak. That could put pressure on the long-term business case.
What is the market capitalization of PHIO?
Phio Pharmaceuticals's market capitalization is $12.20M.
What is the P/E ratio for PHIO stock?
Phio Pharmaceuticals's current P/E ratio is -1.1.
What is the 52-week high for PHIO stock?
The 52-week high for Phio Pharmaceuticals is $4.19. The current close of $1.05 is 74.9% below that high.
What is the 52-week low for PHIO stock?
The 52-week low for Phio Pharmaceuticals is $0.81. The current close of $1.05 is 29.2% above that low.
Does PHIO stock pay dividends?
Phio Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for PHIO?
Phio Pharmaceuticals's Debt / Equity ratio is 0.